Advertisement
Screener

ENTERA BIO LTD. (ENTX) Pre-Tax Margin

ENTERA BIO LTD. (ENTX) Pre-Tax Margin

  • 2024-12-31: Pre-Tax Margin -2858.54%.
  • 2024-09-30: Pre-Tax Margin -7192.86%.
  • 2022-12-31: Pre-Tax Margin -22007.14%.
  • 2022-09-30: Pre-Tax Margin -35912.50%.

Complete source-backed pre-tax margin history.

Available history
2020-12-31 to 2025-12-31
Data captured

Historical Pre-Tax Margin

DatePre-Tax Margin
2024-12-31-2858.54%
2024-09-30-7192.86%
2022-12-31-22007.14%
2022-09-30-35912.50%
2022-06-30-7247.73%
2022-03-31-5575.00%
2021-12-31-2493.94%
2021-09-30-2305.00%
2021-06-30-2379.82%
2021-03-31-1471.34%

Annual Pre-Tax Margin

DatePre-Tax Margin
2025-12-31-27235.71%
2024-12-31-5263.54%
2022-12-31-9652.24%
2021-12-31-2144.66%
2020-12-31-3067.40%

Similar stocks

Stock NameCountryMarket CapPE Ratio
REGENXBIO Inc. (RGNX)United States$0.477B-3.30
Tectonic Therapeutic, Inc. (TECX)United States$0.469B-7.68
Autolus Therapeutics plc (AUTL)$0.506B-1.52
Eikon Therapeutics, Inc. (EIKN)United States$0.446B
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Prime Medicine, Inc. (PRME)United States$0.557B-3.54
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Zura Bio Ltd (ZURA)$0.398B-6.56
Allogene Therapeutics, Inc. (ALLO)United States$0.574B-4.33